Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Cauli

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
Seminars in Arthritis and Rheumatism|September 6, 2025
Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in SpA: findings from the DEUS multicentre studyStefano Di Donato, Gianluca Smerilli, Andrea Becciolini, et al.
Frontiers in Immunology|March 30, 2026
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA NetworkValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Seminars in Arthritis and Rheumatism|January 31, 2026
VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registriesFrancesco Gavioli, Valeria Caggiano, Jessica Sbalchiero, et al.
Seminars in Arthritis and Rheumatism|March 30, 2024
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registryAntonio Vitale, Valeria Caggiano, Eduardo Martin-Nares, et al.
Frontiers in Pharmacology|March 6, 2025
Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registryAntonio Vitale, Valeria Caggiano, Flavia Leone, et al.
Frontiers in Pharmacology|March 24, 2025
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA networkAntonio Vitale, Flavia Leone, Valeria Caggiano, et al.
The European Respiratory Journal|April 9, 2021
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)Alessandra Bettiol, Renato Alberto Sinico, Franco Schiavon, et al.
Frontiers in Immunology|May 27, 2024
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registriesAntonio Vitale, Valeria Caggiano, Abdurrahman Tufan, et al.
Journal of Autoimmunity|April 21, 2026
Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR databaseFlorian Käs, Muriel Elhai, Mike O Becker, et al.
Internal and Emergency Medicine|July 13, 2022
Development and implementation of the AIDA International Registry for patients with Behçet's diseaseAntonio Vitale, Francesca Della Casa, Gaafar Ragab, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Seminars in Arthritis and Rheumatism|September 6, 2025
Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in SpA: findings from the DEUS multicentre studyStefano Di Donato, Gianluca Smerilli, Andrea Becciolini, et al.
Frontiers in Immunology|March 30, 2026
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA NetworkValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Seminars in Arthritis and Rheumatism|January 31, 2026
VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registriesFrancesco Gavioli, Valeria Caggiano, Jessica Sbalchiero, et al.
Seminars in Arthritis and Rheumatism|March 30, 2024
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registryAntonio Vitale, Valeria Caggiano, Eduardo Martin-Nares, et al.
Frontiers in Pharmacology|March 6, 2025
Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registryAntonio Vitale, Valeria Caggiano, Flavia Leone, et al.
Frontiers in Pharmacology|March 24, 2025
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA networkAntonio Vitale, Flavia Leone, Valeria Caggiano, et al.
The European Respiratory Journal|April 9, 2021
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)Alessandra Bettiol, Renato Alberto Sinico, Franco Schiavon, et al.
Frontiers in Immunology|May 27, 2024
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registriesAntonio Vitale, Valeria Caggiano, Abdurrahman Tufan, et al.
Journal of Autoimmunity|April 21, 2026
Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR databaseFlorian Käs, Muriel Elhai, Mike O Becker, et al.
Internal and Emergency Medicine|July 13, 2022
Development and implementation of the AIDA International Registry for patients with Behçet's diseaseAntonio Vitale, Francesca Della Casa, Gaafar Ragab, et al.
Pageof 18